Qing Wen Huang
Net worth: 5 M $ as of 2024-03-30
Profile
Qing Wen Huang worked as a Director at Guangdong Eashu Pharmaceutical Co., Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-12-28 | 5,519,480 ( 2.52% ) | 5 M $ | 2024-03-30 |
Former positions of Qing Wen Huang
Companies | Position | End |
---|---|---|
Guangdong Eashu Pharmaceutical Co., Ltd.
Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Director/Board Member | - |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Guangdong Eashu Pharmaceutical Co., Ltd.
Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Health Technology |
- Stock Market
- Insiders
- Qing Wen Huang